NEW YORK (360DX) – The quality of hemoglobin A1c diabetes testing varies not just from laboratory to laboratory, but from country to country and test manufacturer to test manufacturer, according to findings of a massive multicountry trial conducted by the International Federation of Clinical Chemistry and Laboratory Medicine.
Get the full story with
360Dx Premium
Only $95 for the
first 90 days*
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.